Amore Al Dente Le food truck d’Amore Al Dente ne passe pas inaperçu. Au volant de son ancienne Citroën Type H, Marika propose à ses clients de découvrir la gastronomie italienne en mode street food.…
Can private businesses enforce their own COVID-19 ‘vaccine…
Most Canadian provinces are still on the fence about whether they will implement a domestic COVID-19 “vaccine passport” to allow access to some public places, but what leeway do private businesses have to introduce their…
Australia COVID: The great lie at the heart…
The problem began, as it so often does, with outsourcing. Overwhelmed by the complexity of the pandemic Australia’s political class wisely sought to tap expert medical advice. What wasn’t wise was proffering that advice as…
NSW COVID-19 lockdown set to be extended by…
NSW Premier Gladys Berejiklian is expected to announce today an extension of the state's COVID-19 lockdown orders as well as new restrictions for schools returning from holidays.Key points:More than 330 locally acquired cases of COVID-19 have been recorded since…
Surging Covid and unlocking: does England risk being…
Covid cases in the UK are rising exponentially, largely in younger age groups who are more likely to be partially or completely unvaccinated. What does this mean for the risk of new variants popping up?How…
Made-in-Malaysia Covid-19 vaccine expected to be ready in…
PETALING JAYA: The Covid-19 vaccine currently in development in Malaysia is also being designed as a booster shot, says Institute for Medical Research (IMR) director Dr Tahir Aris. “Those who are fully vaccinated may need…
Covid: Sage scientist fears England could repeat ‘mistakes…
A scientific adviser to the government’s Covid-19 response has expressed fears England could be in danger of repeating “the mistakes of last summer”.Prof Stephen Reicher, from the University of St Andrews and a member of…
AstraZeneca’s antibody cocktail failed to prevent COVID-19 symptoms…
AstraZeneca said on Tuesday a late-stage trial failed to provide evidence that its COVID-19 antibody therapy protected people who had contact with an infected person from the disease, a small setback in its efforts to…
Novavax COVID-19 vaccine more than 90% effective in…
Novavax Inc (NVAX.O) on Monday said its COVID-19 vaccine was more than 90% effective, including against a variety of concerning variants of the coronavirus in a large, late-stage U.S.-based clinical trial.The study of nearly 30,000…